The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
150 jobs Number of planned job creations
Announcement Date
18 May 2015
Employment effect (start)
Foreseen end date
Description
Anglo-Swedish pharmaceutical company AstraZeneca is to hire between 150 and 250 new workers by 2019 at one of the company's sites in Gärtuna outside Södertälje(Sweden).
AstraZeneca recently announced an investment worth SEK 2,3 billion (€ 245 million) in a new high-tech facility for biological drugs in Södertälje. The facility is estimated to require between 150 and 250 highly skilled workers.
Eurofound (2015), AstraZeneca, Business expansion in Sweden, factsheet number 83060, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/83060.